Nucleic Acid-Sensing Pathways During SARS-CoV-2 Infection: Expectations versus Reality

Bushra Mdkhana,1 Narjes Saheb Sharif-Askari,1 Rakhee K Ramakrishnan,1 Swati Goel,1 Qutayba Hamid,1– 3 Rabih Halwani1,2 1Sharjah Institute of Medical Research, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; 2Department of Clinical Sciences, College of Medicine, U...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mdkhana B, Saheb-Sharif Askari N, Ramakrishnan RK, Goel S, Hamid Q, Halwani R
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/1d9b6ee24c174e1d9c3c7a0574a07e11
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1d9b6ee24c174e1d9c3c7a0574a07e11
record_format dspace
spelling oai:doaj.org-article:1d9b6ee24c174e1d9c3c7a0574a07e112021-12-02T14:08:53ZNucleic Acid-Sensing Pathways During SARS-CoV-2 Infection: Expectations versus Reality1178-7031https://doaj.org/article/1d9b6ee24c174e1d9c3c7a0574a07e112021-01-01T00:00:00Zhttps://www.dovepress.com/nucleic-acid-sensing-pathways-during-sars-cov-2-infection-expectations-peer-reviewed-article-JIRhttps://doaj.org/toc/1178-7031Bushra Mdkhana,1 Narjes Saheb Sharif-Askari,1 Rakhee K Ramakrishnan,1 Swati Goel,1 Qutayba Hamid,1– 3 Rabih Halwani1,2 1Sharjah Institute of Medical Research, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; 2Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; 3Meakins-Christie Laboratories, Research Institute of the McGill University Health Center, Montreal, Quebec, CanadaCorrespondence: Rabih HalwaniCollege of Medicine, University of Sharjah, Sharjah, United Arab EmiratesEmail rhalwani@sharjah.ac.aeAbstract: The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people and crippled economies worldwide. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for this pandemic has triggered avid research on its pathobiology to better understand the pathophysiology of COVID-19. In the absence of approved antiviral therapeutic strategies or vaccine platforms capable of effectively targeting this global threat, the hunt for effective therapeutics has led to many candidates being actively evaluated for their efficacy in controlling or preventing COVID-19. In this review, we gathered current evidence on the innate nucleic acid-sensing pathways expected to be elicited by SARS-CoV-2 and the immune evasion mechanisms they have developed to promote viral replication and infection. Within the nucleic acid-sensing pathways, SARS-CoV-2 infection and evasion mechanisms trigger the activation of NOD-signaling and NLRP3 pathways leading to the production of inflammatory cytokines, IL-1β and IL-6, while muting or blocking cGAS-STING and interferon type I and III pathways, resulting in decreased production of antiviral interferons and delayed innate response. Therefore, blocking the inflammatory arm and boosting the interferon production arm of nucleic acid-sensing pathways could facilitate early control of viral replication and dissemination, prevent disease progression, and cytokine storm development. We also discuss the rationale behind therapeutic modalities targeting these sensing pathways and their implications in the treatment of COVID-19.Keywords: COVID-19, SARS-CoV-2, innate immune system, nucleic acid sensing, immune evasion, NLRP3, cGAS-STING, coronavirusMdkhana BSaheb-Sharif Askari NRamakrishnan RKGoel SHamid QHalwani RDove Medical Pressarticlecovid-19sars-cov-2innate immune systemnucleic acid sensingimmune evasionnlrp3cgas-stingcoronavirusPathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol Volume 14, Pp 199-216 (2021)
institution DOAJ
collection DOAJ
language EN
topic covid-19
sars-cov-2
innate immune system
nucleic acid sensing
immune evasion
nlrp3
cgas-sting
coronavirus
Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
spellingShingle covid-19
sars-cov-2
innate immune system
nucleic acid sensing
immune evasion
nlrp3
cgas-sting
coronavirus
Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
Mdkhana B
Saheb-Sharif Askari N
Ramakrishnan RK
Goel S
Hamid Q
Halwani R
Nucleic Acid-Sensing Pathways During SARS-CoV-2 Infection: Expectations versus Reality
description Bushra Mdkhana,1 Narjes Saheb Sharif-Askari,1 Rakhee K Ramakrishnan,1 Swati Goel,1 Qutayba Hamid,1– 3 Rabih Halwani1,2 1Sharjah Institute of Medical Research, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; 2Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; 3Meakins-Christie Laboratories, Research Institute of the McGill University Health Center, Montreal, Quebec, CanadaCorrespondence: Rabih HalwaniCollege of Medicine, University of Sharjah, Sharjah, United Arab EmiratesEmail rhalwani@sharjah.ac.aeAbstract: The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people and crippled economies worldwide. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for this pandemic has triggered avid research on its pathobiology to better understand the pathophysiology of COVID-19. In the absence of approved antiviral therapeutic strategies or vaccine platforms capable of effectively targeting this global threat, the hunt for effective therapeutics has led to many candidates being actively evaluated for their efficacy in controlling or preventing COVID-19. In this review, we gathered current evidence on the innate nucleic acid-sensing pathways expected to be elicited by SARS-CoV-2 and the immune evasion mechanisms they have developed to promote viral replication and infection. Within the nucleic acid-sensing pathways, SARS-CoV-2 infection and evasion mechanisms trigger the activation of NOD-signaling and NLRP3 pathways leading to the production of inflammatory cytokines, IL-1β and IL-6, while muting or blocking cGAS-STING and interferon type I and III pathways, resulting in decreased production of antiviral interferons and delayed innate response. Therefore, blocking the inflammatory arm and boosting the interferon production arm of nucleic acid-sensing pathways could facilitate early control of viral replication and dissemination, prevent disease progression, and cytokine storm development. We also discuss the rationale behind therapeutic modalities targeting these sensing pathways and their implications in the treatment of COVID-19.Keywords: COVID-19, SARS-CoV-2, innate immune system, nucleic acid sensing, immune evasion, NLRP3, cGAS-STING, coronavirus
format article
author Mdkhana B
Saheb-Sharif Askari N
Ramakrishnan RK
Goel S
Hamid Q
Halwani R
author_facet Mdkhana B
Saheb-Sharif Askari N
Ramakrishnan RK
Goel S
Hamid Q
Halwani R
author_sort Mdkhana B
title Nucleic Acid-Sensing Pathways During SARS-CoV-2 Infection: Expectations versus Reality
title_short Nucleic Acid-Sensing Pathways During SARS-CoV-2 Infection: Expectations versus Reality
title_full Nucleic Acid-Sensing Pathways During SARS-CoV-2 Infection: Expectations versus Reality
title_fullStr Nucleic Acid-Sensing Pathways During SARS-CoV-2 Infection: Expectations versus Reality
title_full_unstemmed Nucleic Acid-Sensing Pathways During SARS-CoV-2 Infection: Expectations versus Reality
title_sort nucleic acid-sensing pathways during sars-cov-2 infection: expectations versus reality
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/1d9b6ee24c174e1d9c3c7a0574a07e11
work_keys_str_mv AT mdkhanab nucleicacidsensingpathwaysduringsarscov2infectionexpectationsversusreality
AT sahebsharifaskarin nucleicacidsensingpathwaysduringsarscov2infectionexpectationsversusreality
AT ramakrishnanrk nucleicacidsensingpathwaysduringsarscov2infectionexpectationsversusreality
AT goels nucleicacidsensingpathwaysduringsarscov2infectionexpectationsversusreality
AT hamidq nucleicacidsensingpathwaysduringsarscov2infectionexpectationsversusreality
AT halwanir nucleicacidsensingpathwaysduringsarscov2infectionexpectationsversusreality
_version_ 1718391891761823744